摘要
目的通过测定强直性脊柱炎(AS)男性患者血清骨特异性碱性磷酸酶(BALP)、血清骨钙素(sOC)、尿Ⅰ型胶原C末端肽(CTX-Ⅰ)水平,以探讨与疾病活动性、骨密度(BMD)的关系。方法用ELISA方法测定35名AS患者血清BALP、sOC、尿CTX-Ⅰ;用双能X线吸收法(DEXA)测定腰椎正位(AP)L1-L4总体和股骨颈的BMD,根据Bath强直性脊柱炎疾病活动指数(BASDAI)对患者病情进行评分,并与70名健康者对照。结果AS患者尿CTX-Ⅰ水平显著高于对照组(P<0.05);直线相关显示,尿CTX-Ⅰ水平与股骨颈BMD呈负相关(r=-0.414,P<0.05),与BASDAI、C反应蛋白(CRP)呈正相关(r=0.445,P<0.05;r=0.491,P<0.01)。AS患者血清BALP、sOC水平与对照组无统计学意义,且与BMD、BASDAI无明显相关性。结论CTX-Ⅰ水平升高提示患者骨吸收增强、骨密度降低、疾病呈活动性。
Objective To determine the levels of serum bone-specific alkaline phosphatase (BALP), serum osteocalcin(sOC) ,urinary C-terminal telopeptide fragments of type I collagen( CTX- I ) in men with ankylosing spondylitis (AS) and to investigate their associations with disease activity, bone mineral density (BMD). Methods Serum BALP,sOC, urinary CTX- I were determined by enzyme-linked immunosorbent assay in 35 men with AS,areal BMD at the posteroanterior lumbar, spine (L1-4) and femoral neck using dual energy X-ray absorptiometry (DEXA). Bath AS Disease Activity Index (BASDAI) were evaluated. Levels of biochemical markers were compared with those of 70 age-matched healthy men. Results Patients with AS had significantly higher mean urinary CTX-I level than control subjects (P 〈 0. 05 ). Urinary CTX-I levels showed significantly inverse correlations with femoral neck BMD (r = - 0. 414, P = 0. 030) but not with spinal BMD. There were significantly positive correlations between urinary CTX-I levels and BASDAI (r = O. 445, P = 0. 016) as well as between urinary CTX-I and CRP levels (r= 0. 491 ,P = 0. 006). Mean serum BALP and osteocalcin levels did not differ between patients and controls and did not show any significant correlationswith BMD, BASDAI in men with AS. Conclusion Elevated CTX-I reflects bone resorption,loss of femoral BMD and disease activity.
出处
《中国实用医药》
2009年第19期49-51,共3页
China Practical Medicine
关键词
强直性脊柱炎
骨密度
尿Ⅰ型胶原C末端肽
骨特异性碱性磷酸酶
骨钙素
Ankylosing spondylitis (AS)
bone mineral density(BMD)
urinary C-terminal telopeptide fragments of type I collagen( CTX- I )
serum bone-specific alkaline phosphatase(BALP)
serum osteocalcin (sOC)